|An Investigational Study of Gardasil™ (qHPV, V501) Vaccine in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)||
||4065||Male||16 Years to 26 Years (Child, Adult)||NCT00090285||V501-020
|September 24, 2004||July 31, 2009||April 3, 2017||August 27, 2004||May 19, 2017||November 19, 2009|
|2||NCT02503111||Enrolling by invitation||The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men||
||Other / Industry||
||3000||Male||18 Years and older (Adult, Senior)||NCT02503111||HPV-SAVE||HPV-SAVE||November 2015||November 2020||December 2020||July 20, 2015||September 15, 2016||
† Study has passed its completion date and status has not been verified in more than two years.